Navellier & Associates’s BioTelemetry, Inc. BEAT Stock Holding History

Navellier & Associates’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-5,000	Closed	-$231K	–	305
2019 Q4	$231K	Sell	5,000 -8,308	-62%	-$360K	0.04%	263
2019 Q3	$542K	Sell	13,308 -1,276	-9%	-$55.1K	0.09%	168
2019 Q2	$702K	Sell	14,584 -40,099	-73%	-$2.11M	0.11%	162
2019 Q1	$3.42M	Buy	54,683 +20,213	+59%	+$1.39M	0.53%	48
2018 Q4	$2.06M	Buy	34,470 +8,667	+34%	+$520K	0.35%	71
2018 Q3	$1.66M	Buy	+25,803	New	+$1.44M	0.22%	121

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Navellier & Associates's BEAT Position: Q1 2020 in Review

Navellier & Associates sold out of BioTelemetry, Inc. (BEAT) in Q1 2020, closing a stake of 5,000 shares — an estimated $231K sold.

Navellier & Associates first reported a position in BEAT in Q3 2018 and held it in 6 quarters. The position peaked at $3.42M in Q1 2019. 209 funds tracked by Wall St. Rank hold BEAT as of Q1 2020.

Navellier & Associates reported no remaining BioTelemetry, Inc. position as of Q1 2020 after selling out during the quarter.
Navellier & Associates sold 5,000 BioTelemetry, Inc. shares in Q1 2020, an estimated $231K.
Navellier & Associates first reported a position in BioTelemetry, Inc. in Q3 2018 and held it in 6 quarters.
Navellier & Associates's BioTelemetry, Inc. position peaked at $3.42M in Q1 2019.
209 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2020.

Based on Navellier & Associates's 13F filing for Q1 2020, filed 13 May 2020.